Literature DB >> 11244482

Association between Novelty Seeking and the -521 C/T polymorphism in the promoter region of the DRD4 gene.

Z Ronai1, A Szekely, Z Nemoda, K Lakatos, J Gervai, M Staub, M Sasvari-Szekely.   

Abstract

Association between the human personality trait 'Novelty Seeking' and the polymorphism of the DRD4 gene was first reported by Ebstein and Benjamin in 1996. This was soon followed by replication studies in various ethnic groups and by studying the role of other neurotransmitter receptor and transporter genes in the genetic determination of human temperament. More recently, several polymorphic sites of the upstream regulatory region of the DRD4 gene have been described. Among these the -521 C/T single nucleotide polymorphism (SNP) was shown to be associated with the Novelty Seeking (NS) scores of the Temperament and Character Inventory (TCI) in a Japanese male population. We have investigated the -521 C/T SNP polymorphism in a Caucasian (Hungarian) population, and here we report a replication of the Japanese findings, in an association study involving 109 healthy Hungarian volunteers. We found a weak association between NS and CC vs CT or TT genotypes (P < 0.06). Examination of this relation in male and female sex groups, however, strengthened the association for females (P < 0.01), but showed no genotypic effect for males.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244482     DOI: 10.1038/sj.mp.4000832

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  18 in total

Review 1.  Novelty Seeking and Drug Addiction in Humans and Animals: From Behavior to Molecules.

Authors:  Taylor Wingo; Tanseli Nesil; Jung-Seok Choi; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-19       Impact factor: 4.147

Review 2.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

Review 3.  Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?

Authors:  Mark S Gold; Kenneth Blum; Marlene Oscar-Berman; Eric R Braverman
Journal:  Postgrad Med       Date:  2014-01       Impact factor: 3.840

4.  Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.

Authors:  S P David; M R Munafò; M F G Murphy; M Proctor; R T Walton; E C Johnstone
Journal:  Pharmacogenomics J       Date:  2007-03-27       Impact factor: 3.550

5.  The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus.

Authors:  E Wang; Y-C Ding; P Flodman; J R Kidd; K K Kidd; D L Grady; O A Ryder; M A Spence; J M Swanson; R K Moyzis
Journal:  Am J Hum Genet       Date:  2004-04-09       Impact factor: 11.025

6.  Association of a polymorphism of the dopamine receptor D4 gene with bone mineral density in Japanese men.

Authors:  Yoshiji Yamada; Fujiko Ando; Naoakira Niino; Hiroshi Shimokata
Journal:  J Hum Genet       Date:  2003-11-07       Impact factor: 3.172

7.  Relationship between dopamine system genes and extraversion and novelty seeking.

Authors:  V E Golimbet; M V Alfimova; I K Gritsenko; R P Ebstein
Journal:  Neurosci Behav Physiol       Date:  2007-07

Review 8.  Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

9.  Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.

Authors:  Brian E Roe; Michael R Tilley; Howard H Gu; David Q Beversdorf; Wolfgang Sadee; Timothy C Haab; Audrey C Papp
Journal:  PLoS One       Date:  2009-08-20       Impact factor: 3.240

10.  Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence.

Authors:  Andrea Vereczkei; Zsolt Demetrovics; Anna Szekely; Peter Sarkozy; Peter Antal; Agnes Szilagyi; Maria Sasvari-Szekely; Csaba Barta
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.